Suscribirse

Comparison of cementless total hip arthroplasty survivorship between metal-on-highly cross-linked polyethylene and ceramic on ceramic bearings: A case control study with a 5-9-year follow-up - 22/08/18

Doi : 10.1016/j.otsr.2018.04.016 
Yoshitoshi Higuchi , Taisuke Seki, Yukiharu Hasegawa, Daigo Morita, Daigo Komatsu, Yasuhiko Takegami, Naoki Ishiguro
 Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65, Tsurumai-cho, 4668550 Showa-ku, Nagoya city, Aichi prefecture, Japan 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Currently, there is a lack of evidence on the medium-term follow-up of cementless total hip arthroplasty (THA) using metal-on-highly cross-linked polyethylene bearing (MoXPE), ceramic on ceramic bearing (CoC) at more than 5 years follow-up. Therefore, we performed a case control study to: compare the incidence rate of osteolysis; compare the longevity for both types of THAs, and to evaluate the wear rate of MoXPE THAs.

Hypothesis

CoC THAs will have a lower rate of osteolysis and better longevity than MoXPE THAs.

Patients and methods

We performed a retrospective analysis of 77 MoXPE (68 women, 9 men) and 105 CoC (85 women, 20 men) THAs, with an average patient age at the time of surgery of 64.7 years (range, 27 to 76 years). The cohorts were matched according to sex, body mass index, or diagnosis of hip joint disease. Clinical and radiologic measurements were analyzed at a mean follow-up of 6.7 years (range, 5–9 years).

Results

There were no between-group differences with regard to the Harris hip score (87.0 [64.0–98.0] and 89.9 [70.0–100.0] for the MoXPE and CoC group, respectively) and the incidence rate of osteolysis (2.6% and 1.9%, respectively). Revision was required for 1 case for each THA type. The Kaplan-Meier survival at 8 years, using implant loosening or revision as the end-point of analysis, was 96.1% (95% confidence interval [CI], 90.0–99.3) for the MoXPE group and 98.9% (95% CI, 92.2–99.8) for the CoC group (p=0.189). The mean annual liner wear rate was 0.0160mm/year (range, 0.0050 to 0.0390mm/year) for the MoXPE THAs.

Discussion

There was no difference between CoC and MoXPE THAs in the incidence of osteolysis or in survival rate at 8 years post-surgery. Excellent clinical and radiological outcomes were obtained for both types of bearings.

Level of evidence

III, Case control study, case control retrospective design.

El texto completo de este artículo está disponible en PDF.

Keywords : Ceramic on ceramic bearing, Metal-on-highly cross-linked polyethylene bearing, Total hip arthroplasty, Wear


Esquema


© 2018  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 104 - N° 5

P. 663-669 - septembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • Translation, cross-cultural adaption and validation of the French version of the Forgotten Joint Score in total hip arthroplasty
  • Shahnaz Klouche, Johannes M. Giesinger, El-Hadi Sariali
| Artículo siguiente Artículo siguiente
  • Optimal timing for elective total hip replacement in HIV-positive patients
  • Chun-Hung Chang, Shang-Wen Tsai, Cheng-Fong Chen, Po-Kuei Wu, Wing-Wai Wong, Ming-Chau Chang, Wei-Ming Chen

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.